0001104659-21-090746.txt : 20210709 0001104659-21-090746.hdr.sgml : 20210709 20210709182856 ACCESSION NUMBER: 0001104659-21-090746 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210707 FILED AS OF DATE: 20210709 DATE AS OF CHANGE: 20210709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Mark K. CENTRAL INDEX KEY: 0001786183 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39202 FILM NUMBER: 211083875 MAIL ADDRESS: STREET 1: 227 7TH AVENUE NE CITY: ST. PETERSBURG STATE: FL ZIP: 33701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Annovis Bio, Inc. CENTRAL INDEX KEY: 0001477845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262540421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1055 WESTLAKES DRIVE, SUITE 300 CITY: BERWYN STATE: PA ZIP: 19312 BUSINESS PHONE: 610-727-3913 MAIL ADDRESS: STREET 1: 1055 WESTLAKES DRIVE, SUITE 300 CITY: BERWYN STATE: PA ZIP: 19312 FORMER COMPANY: FORMER CONFORMED NAME: QR Pharma, Inc. DATE OF NAME CHANGE: 20091202 4 1 tm2121908-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-07-07 0 0001477845 Annovis Bio, Inc. ANVS 0001786183 White Mark K. C/O ANNOVIS BIO, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 1 0 0 0 Stock Option (right to buy) 102.85 2021-07-07 4 A 0 4000 0 A 2031-07-07 Common Stock 4000 4000 D The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date. /s/ Jeffrey McGroarty, Attorney-in-Fact for Mark White 2021-07-09